141 related articles for article (PubMed ID: 8991644)
21. Immunoglobulin M and G immunoblots in the diagnosis of parvovirus B19 infection.
Chen MY; Lee KL; Hung CC
J Formos Med Assoc; 2000 Jan; 99(1):24-32. PubMed ID: 10743343
[TBL] [Abstract][Full Text] [Related]
22. Accurate serodiagnosis of B19 parvovirus infections by measurement of IgG avidity.
Söderlund M; Brown CS; Cohen BJ; Hedman K
J Infect Dis; 1995 Mar; 171(3):710-3. PubMed ID: 7876624
[TBL] [Abstract][Full Text] [Related]
23. Identification of an immunodominant peptide in the parvovirus B19 VP1 unique region able to elicit a long-lasting immune response in humans.
Zuffi E; Manaresi E; Gallinella G; Gentilomi GA; Venturoli S; Zerbini M; Musiani M
Viral Immunol; 2001; 14(2):151-8. PubMed ID: 11398810
[TBL] [Abstract][Full Text] [Related]
24. Epitope type-specific IgG responses to capsid proteins VP1 and VP2 of human parvovirus B19.
Söderlund M; Brown CS; Spaan WJ; Hedman L; Hedman K
J Infect Dis; 1995 Dec; 172(6):1431-6. PubMed ID: 7594699
[TBL] [Abstract][Full Text] [Related]
25. Design and production of a target-specific monoclonal antibody to parvovirus B19 capsid proteins.
Kerr JR; O'Neill HJ; Deleys R; Wright C; Coyle PV
J Immunol Methods; 1995 Mar; 180(1):101-6. PubMed ID: 7534801
[TBL] [Abstract][Full Text] [Related]
26. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection.
Von Landenberg P; Lehmann HW; Knöll A; Dorsch S; Modrow S
Arthritis Rheum; 2003 Jul; 48(7):1939-47. PubMed ID: 12847688
[TBL] [Abstract][Full Text] [Related]
27. Detection of parvovirus B19 NS1-specific antibodies by ELISA and western blotting employing recombinant NS1 protein as antigen.
Heegaard ED; Rasksen CJ; Christensen J
J Med Virol; 2002 Jul; 67(3):375-83. PubMed ID: 12116031
[TBL] [Abstract][Full Text] [Related]
28. Prolonged parvovirus b19 viremia in spite of neutralizing antibodies after erythema infectiosum in pregnancy.
Dobec M; Juchler A; Flaviano A; Kaeppeli F
Gynecol Obstet Invest; 2007; 63(1):53-4. PubMed ID: 16940737
[TBL] [Abstract][Full Text] [Related]
29. Antibodies to the nonstructural protein of parvovirus B19 in persistently infected patients: implications for pathogenesis.
von Poblotzki A; Hemauer A; Gigler A; Puchhammer-Stöckl E; Heinz FX; Pont J; Laczika K; Wolf H; Modrow S
J Infect Dis; 1995 Nov; 172(5):1356-9. PubMed ID: 7594677
[TBL] [Abstract][Full Text] [Related]
30. [Seroepidemiology of human parvovirus B19 using recombinant VP1 + VP2 particle antigen].
Matsunaga Y; Takeda N; Yamazaki S; Kamata K; Kurosawa D
Kansenshogaku Zasshi; 1995 Dec; 69(12):1371-5. PubMed ID: 8586889
[TBL] [Abstract][Full Text] [Related]
31. A school outbreak of parvovirus B19 infection investigated using salivary antibody assays.
Rice PS; Cohen BJ
Epidemiol Infect; 1996 Jun; 116(3):331-8. PubMed ID: 8666078
[TBL] [Abstract][Full Text] [Related]
32. Human parvovirus B19 and rheumatoid arthritis.
Taylor HG; Borg AA; Dawes PT
Clin Rheumatol; 1992 Dec; 11(4):548-50. PubMed ID: 1486749
[TBL] [Abstract][Full Text] [Related]
33. Parvovirus B19 viral loads in relation to VP1 and VP2 antibody responses in diagnostic blood samples.
Beersma MF; Claas EC; Sopaheluakan T; Kroes AC
J Clin Virol; 2005 Sep; 34(1):71-5. PubMed ID: 15985386
[TBL] [Abstract][Full Text] [Related]
34. Human parvovirus B19 specific IgG, IgA, and IgM antibodies and DNA in serum specimens from persons with erythema infectiosum.
Erdman DD; Usher MJ; Tsou C; Caul EO; Gary GW; Kajigaya S; Young NS; Anderson LJ
J Med Virol; 1991 Oct; 35(2):110-5. PubMed ID: 1765775
[TBL] [Abstract][Full Text] [Related]
35. Human parvovirus B19-associated arthritis in children.
Nocton JJ; Miller LC; Tucker LB; Schaller JG
J Pediatr; 1993 Feb; 122(2):186-90. PubMed ID: 8429430
[TBL] [Abstract][Full Text] [Related]
36. [Parvovirus B19 infection: the general aspects and gestational problems].
Di Stefano L; Carta G; Barnabei R; Tomei E; Toro G; Moscarini M
Minerva Ginecol; 1995 Apr; 47(4):121-5. PubMed ID: 7644092
[TBL] [Abstract][Full Text] [Related]
37. Human parvovirus B19 serology and avidity using a combination of recombinant antigens enables a differentiated picture of the current state of infection.
Pfrepper KI; Enders M; Motz M
J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):362-5. PubMed ID: 16316402
[TBL] [Abstract][Full Text] [Related]
38. Seroprevalence of IgG against conformational and linear capsid antigens of parvovirus B19 in Italian blood donors.
Manaresi E; Gallinella G; Morselli Labate AM; Zucchelli P; Zaccarelli D; Ambretti S; Delbarba S; Zerbini M; Musiani M
Epidemiol Infect; 2004 Oct; 132(5):857-62. PubMed ID: 15473148
[TBL] [Abstract][Full Text] [Related]
39. Parvovirus B19 antibodies in sera of patients with unexplained exanthemata from Belém, Pará, Brazil.
de Freitas RB; de Miranda MF; Shirley J; Tudor R; Desselberger U; Linhares AC
Mem Inst Oswaldo Cruz; 1993; 88(3):497-9. PubMed ID: 8107612
[No Abstract] [Full Text] [Related]
40. Reactivity of genotype-specific recombinant proteins of human erythrovirus B19 with plasmas from areas where genotype 1 or 3 is endemic.
Parsyan A; Kerr S; Owusu-Ofori S; Elliott G; Allain JP
J Clin Microbiol; 2006 Apr; 44(4):1367-75. PubMed ID: 16597864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
